The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 08, 2016
Filed:
May. 08, 2015
Applicant:
Jazz Pharmaceuticals Ireland Limited, Dublin, IE;
Inventor:
Mark Eller, Redwood City, CA (US);
Assignee:
Jazz Pharmaceuticals Ireland Limited, Dublin, IE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 37/36 (2006.01); A61K 31/19 (2006.01); A61K 31/616 (2006.01); A61K 31/20 (2006.01); A61K 31/33 (2006.01); A61K 31/505 (2006.01); A61K 31/55 (2006.01);
U.S. Cl.
CPC ...
A61K 31/19 (2013.01); A61K 31/20 (2013.01); A61K 31/33 (2013.01); A61K 31/505 (2013.01); A61K 31/55 (2013.01); A61K 31/616 (2013.01);
Abstract
One embodiment of the present invention is to improve the safety and efficacy of the administration of GHB or a salt thereof to a patient. It has been discovered that the concomitant administration of an MCT inhibitor, such as diclofenac, valproate, or ibuprofen, will affect GHB administration. For example, it has been discovered that diclofenac lowers the effect of GHB in the body, thereby potentially causing an unsafe condition. Furthermore, it has been discovered that valproate increases the effect of GHB on the body, thereby potentially causing an unsafe condition.